ProJenX
Nissequogue, NY
ProJenX is a biopharmaceutical company that develops novel small molecule therapeutics that target motor neuron degenerative pathways. The company was founded in 2021 and is headquartered in Nissequogue, New York.
projenx.comCompany Details
Founded
- 2021
Employees
- Between 2 - 10 employees
Raised
- $21,100,000
Headquarters Location
- Nissequogue, NY
Public
- No
Acquired
- No
CEO
Eric Heil
Founders
- Erin Fleming
Company Collections
These are collections ProJenX is a part of. Click on the collection name to view similar companies.